Animal Cancer Institute Trials
Since its inception the Animal Cancer Institute and its Network of veterinary oncologists have offered cutting edge treatment options to the metropolitan D.C. area. In the last six months the Animal Cancer Institute Network has expanded across the United States, with newly active treatment sites in New York, Florida, Texas, and California.
It is the goal of the Animal Cancer Institute to provide more effective and less toxic options for the treatment of cancer. Collaboration with the pharmaceutical industry allows these options to be provided, in many cases at no cost. For more information on the Animal Cancer Institute, visit our website at:www.animalcancerinstitute.com.
The Animal Cancer Institute, LLC
Cutting edge options for cancer
C. Khanna DVM, PhD, DACVIM
T. Rusk DVM
For more information contact Jennifer Turner
You may register your clinic to receive electronic updates on trials available to your clients. Registration for eTrial Updates is available at our website, www.animalcancerinstitute.com.
The Animal Cancer Institute in cooperation with the AMC Cancer Research Center is looking for assistance in a canine cancer research study. The project involves collection of histopathology samples on purebred dogs with osteosarcoma. The purpose of the analysis is to determine how genes impact the development of osteosarcoma in dogs.
Study eligibility criteria include:
• Golden Retrievers, Rottweilers, Scottish Deerhounds and Mastiffs with known pedigrees can participate in this study. Other breeds may be eligible upon approval by the Animal Cancer Institute.
• Dogs must have a diagnosis of appendicular osteosarcoma (Grades I-II), with no evidence of metastatic disease.
• There must be at least two unaffected first-degree relatives of the affected dog (parents, siblings, or offspring) that will consent to participation through the donation of 10-15 ml of EDTA-anticoagulated blood (samples from unaffected relatives are not required at the time of diagnosis or sample submission from the affected patient).
• Informed owner consent form authorizing pre-treatment excisional biopsy (to be collected in a medium supplied by the AMC), and commitment for treatment with an acceptable protocol (e.g. amputation or limb-sparing surgery and systemic chemotherapy with Cisplatin, Carboplatin, Adriamycin, or a combination thereof).
Trial Support/Funding Includes:
• $150 stipend toward cost of biopsy • Histopathology and shipping of samples (an approximate value of $130) will be performed at no charge by the AMC Cancer Research Center .
For more information please contact Jen Turner at the Animal Cancer Institute (202) 363-7300 or see our website at: www.animalcancerinstitute.com